- Home
- HSCS vs TLPH Comparison
HSCS vs TLPH Comparison
Compare HSCS & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSCS
- TLPH
- Stock Information
- Founded
- HSCS 2007
- TLPH 2005
- Country
- HSCS United States
- TLPH United States
- Employees
- HSCS N/A
- TLPH N/A
- Industry
- HSCS Medical Specialities
- TLPH Biotechnology: Pharmaceutical Preparations
- Sector
- HSCS Health Care
- TLPH Health Care
- Exchange
- HSCS Nasdaq
- TLPH Nasdaq
- Market Cap
- HSCS 9.9M
- TLPH 11.1M
- IPO Year
- HSCS 2022
- TLPH 2011
- Fundamental
- Price
- HSCS $3.16
- TLPH $1.28
- Analyst Decision
- HSCS Strong Buy
- TLPH Strong Buy
- Analyst Count
- HSCS 2
- TLPH 1
- Target Price
- HSCS $10.50
- TLPH $6.00
- AVG Volume (30 Days)
- HSCS 25.5K
- TLPH 491.4K
- Earning Date
- HSCS 12-15-2025
- TLPH 11-12-2025
- Dividend Yield
- HSCS N/A
- TLPH N/A
- EPS Growth
- HSCS N/A
- TLPH N/A
- EPS
- HSCS N/A
- TLPH N/A
- Revenue
- HSCS $6,250.00
- TLPH $27,000.00
- Revenue This Year
- HSCS N/A
- TLPH N/A
- Revenue Next Year
- HSCS N/A
- TLPH $14,533.26
- P/E Ratio
- HSCS N/A
- TLPH N/A
- Revenue Growth
- HSCS N/A
- TLPH N/A
- 52 Week Low
- HSCS $2.52
- TLPH $0.38
- 52 Week High
- HSCS $6.47
- TLPH $1.45
- Technical
- Relative Strength Index (RSI)
- HSCS 36.80
- TLPH 67.99
- Support Level
- HSCS $3.16
- TLPH $1.12
- Resistance Level
- HSCS $3.43
- TLPH $1.19
- Average True Range (ATR)
- HSCS 0.16
- TLPH 0.11
- MACD
- HSCS -0.04
- TLPH -0.01
- Stochastic Oscillator
- HSCS 1.67
- TLPH 74.18
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.